WuXi Biologics (Cayman) I...

OTC: WXIBF · Real-Time Price · USD
4.00
0.10 (2.56%)
At close: Aug 15, 2025, 12:21 PM
3.90
-2.50%
After-hours: Aug 13, 2025, 08:00 PM EDT

WuXi Biologics (Cayman) Income Statement

Financials in CNY. Fiscal year is January - December.
Fiscal Year Q4 2024 Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
Period Ending Dec 31, 2024 Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
Revenue
10.1B 8.57B 8.54B 8.49B 8.06B 7.21B 5.88B 4.41B
Cost of Revenue
5.8B 5.22B 5.27B 4.93B 4.75B 3.79B 3.35B 2.11B
Gross Profit
4.3B 3.35B 3.27B 3.56B 3.31B 3.41B 2.53B 2.3B
Operating Income
3.15B 1.82B 1.65B 2.3B 1.87B 2.48B 1.53B 1.64B
Interest Income
350.37M n/a 64.67M 3.98M 21.75M 34.73M 16.46M 6.51M
Pretax Income
2.83B 2.01B 1.64B 2.53B 2.43B 2.93B 1.93B 2.06B
Net Income
1.86B 1.5B 1.13B 2.27B 1.89B 2.54B 1.55B 1.84B
Selling & General & Admin
960.9M 1.19B 1.17B 915.69M 1.04B 651.78M 599.13M 533.82M
Research & Development
422.38M 344.06M 451.14M 341.44M 418.44M 271.13M 392.46M 115.38M
Other Expenses
-236.54M n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
1.15B 1.53B 1.62B 1.03B 904.92M 512.73M 610.59M 244.02M
Interest Expense
157.59M n/a n/a n/a 93.89M 557.83M 11.33M 231.23M
Selling & Marketing Expenses
250.54M 223.06M 188.62M 105.39M 95.81M 67.1M 64.29M 60.36M
Cost & Expenses
6.95B 6.75B 6.9B 5.96B 5.66B 4.31B 3.96B 2.35B
Income Tax Expense
660.96M 228.07M 412.06M 191.12M 498.95M 308.91M 309.09M 175.45M
Shares Outstanding (Basic)
4.08B 4.3B 4.49B 4.36B 4.39B 4.37B 4.42B 4.39B
Shares Outstanding (Diluted)
4.23B 4.26B 4.35B 4.35B 4.37B 4.39B 4.44B 4.41B
EPS (Basic)
-0.24 0.35 0.26 0.52 0.42 0.58 0.36 0.42
EPS (Diluted)
-0.24 0.35 0.26 0.52 0.44 0.58 0.34 0.42
EBITDA
3.96B 2.47B 2.13B 2.85B 2.17B 2.9B 1.7B 1.93B
EBIT
3.17B 1.82B 1.63B 2.3B 1.87B 2.48B 1.53B 1.64B
Depreciation & Amortization
783.73M 653.32M 497.73M 359.31M 300.5M 418.13M 167.44M 284.8M